← Eichor
Condition: Immune Checkpoint Inhibitors Icis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Immune Checkpoint Inhibitors Icis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Fruquintinib After ICIs Treatment in Unresectable Hepatocellular Carcinoma
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT06446154The Impact of Emotional Stress on Immunotherapy Outcomes in Liver Cancer Patients: A Multi-Cohort Study
Phase N/A · 5 location(s) · Guilin Medical University, China · NCT07141056ICIs and Anti-VEGF Antibody/TKIs With or Without Interventional Therapy for Advanced HCC
Phase 2 · 1 location(s) · Peking Union Medical College Hospital · NCT07157969A Real-world Study of the Efficacy and Safety of ICIs as First-line Therapy for Advanced Malignancies
Phase N/A · 1 location(s) · Xinqiao Hospital of Chongqing · NCT05862259Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLC
NA · 2 location(s) · Xinqiao Hospital of Chongqing · NCT05754203The Effect of Chronic Stress on Efficacy of ICIs in Esophageal Cancer Patients (STRESS-ESCA Study)
Phase N/A · 1 location(s) · Second Xiangya Hospital of Central South University · NCT05967910Bevacizumab and ICIs + hSRT in Symptomatic Melanoma Brain Metastases
Phase 1/Phase 2 · 1 location(s) · Melanoma and Skin Cancer Trials Limited · NCT06163820Neoantigen Vaccines in Esophageal Squamous Cell Carcinoma
Phase 2 · 1 location(s) · Sichuan University · NCT06675201ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immuno
Phase 2 · 20 location(s) · Second Xiangya Hospital of Central South University · NCT06951646A Study of the Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents
NA · 1 location(s) · Sun Yat-sen University · NCT05718492Efficacy and Safety of HGXJT in Bone Metastatic NSCLC Patients
NA · 1 location(s) · Guangzhou University of Traditional Chinese Medicine · NCT05378334DC Combined With ICIs in the Treatment of Advanced Lung Cancer Resistant to ICIs
EARLY_Phase 1 · 1 location(s) · Zhen-Yu Ding · NCT06329908Efficacy and Safety of ALSS Treatment for ICIs-LF in Patients With HCC
NA · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT05484908TACE Combined With ICIs Plus MTT After 125I Irradiation Stent Placement in HCC With Main PVTT.
Phase N/A · 1 location(s) · Zhongda Hospital · NCT06669377Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint
Phase N/A · 5 location(s) · Beijing Chao Yang Hospital · NCT06950697
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.